KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Inventory: 2009-2025

Historic Inventory for Neogenomics (NEO) over the last 16 years, with Sep 2025 value amounting to $28.5 million.

  • Neogenomics' Inventory rose 16.37% to $28.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 16.37%. This contributed to the annual value of $26.7 million for FY2024, which is 10.73% up from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Inventory is $28.5 million, which was down 16.71% from $34.2 million recorded in Q2 2025.
  • Neogenomics' 5-year Inventory high stood at $34.2 million for Q2 2025, and its period low was $20.3 million during Q1 2024.
  • For the 3-year period, Neogenomics' Inventory averaged around $25.9 million, with its median value being $24.5 million (2024).
  • Per our database at Business Quant, Neogenomics' Inventory dropped by 20.76% in 2021 and then surged by 47.20% in 2025.
  • Over the past 5 years, Neogenomics' Inventory (Quarterly) stood at $23.4 million in 2021, then increased by 3.77% to $24.3 million in 2022, then dropped by 0.50% to $24.2 million in 2023, then rose by 10.73% to $26.7 million in 2024, then climbed by 16.37% to $28.5 million in 2025.
  • Its last three reported values are $28.5 million in Q3 2025, $34.2 million for Q2 2025, and $29.8 million during Q1 2025.